Chemical activators of C16orf92 can trigger its activation through various intracellular signaling pathways. The calcium ionophore A23187, for example, can facilitate the influx of calcium into the cell, which in turn can activate calmodulin-dependent protein kinases. These kinases have the capacity to phosphorylate and thereby activate C16orf92. Similarly, ionomycin increases intracellular Ca2+ concentration, potentially activating C16orf92 via calcium-dependent phosphorylation pathways. Another activator, Phorbol 12-myristate 13-acetate (PMA), directly activates protein kinase C (PKC). Activated PKC can phosphorylate various substrates within the cell, which may include C16orf92, thus contributing to its activation. In the same vein, Forskolin raises cAMP levels, which activates protein kinase A (PKA). PKA then can phosphorylate and activate C16orf92. Insulin, through its receptor, initiates the PI3K/Akt signaling pathway, culminating in the activation of downstream proteins, potentially including C16orf92, by phosphorylation.
In addition to these, Epidermal Growth Factor (EGF) binds to its receptor and activates the MAPK/ERK pathway, which can lead to the phosphorylation and subsequent activation of C16orf92. Oxidative stress, for instance, induced by Hydrogen peroxide, can inhibit phosphatases, leading to a reduced dephosphorylation rate and thus, an increased phosphorylation state of C16orf92. S-Nitroso-N-acetylpenicillamine (SNAP) releases nitric oxide, which in turn can elevate cGMP levels and activate protein kinase G (PKG). PKG can phosphorylate and activate C16orf92. Lithium Chloride, by inhibiting GSK-3β, may lead to activation of C16orf92 through a reduction in inhibitory phosphorylation. BAY 11-7082, by inhibiting the NF-κB signaling pathway, alters cellular signaling in a way that can activate C16orf92. Anisomycin activates stress-activated protein kinases (SAPKs), which in turn can phosphorylate and activate C16orf92. Lastly, Okadaic Acid inhibits protein phosphatases 1 and 2A, potentially leading to the activation of C16orf92 as a result of sustained phosphorylation. Each of these chemicals, through its unique mechanism, can activate the C16orf92 protein by influencing the phosphorylation state or the signaling pathways that converge on C16orf92.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Increases intracellular calcium levels, which activates calmodulin-dependent protein kinases that can phosphorylate and activate C16orf92. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Directly activates protein kinase C (PKC) which, in turn, may phosphorylate and activate C16orf92 as part of intracellular signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular Ca2+ concentration, potentially activating C16orf92 through calcium-dependent phosphorylation pathways. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Activates the PI3K/Akt signaling pathway, leading to the phosphorylation and activation of a variety of downstream proteins, which could include C16orf92. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Acts as an oxidative stress agent that may inhibit phosphatases, leading to increased phosphorylation and activation of C16orf92 due to decreased dephosphorylation. | ||||||
(±)-S-Nitroso-N-acetylpenicillamine | 79032-48-7 | sc-200319B sc-200319 sc-200319A | 10 mg 20 mg 100 mg | $74.00 $114.00 $374.00 | 18 | |
Releases nitric oxide which increases cGMP levels and activates PKG that could phosphorylate and activate C16orf92. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β potentially leading to the activation of C16orf92 through decreased inhibitory phosphorylation. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits NF-κB pathway, which could lead to the activation of C16orf92 through altered signaling pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates stress-activated protein kinases (SAPKs), which could phosphorylate and activate C16orf92. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases 1 and 2A, potentially leading to the activation of C16orf92 through sustained phosphorylation. | ||||||